NCT05032573

Brief Summary

This is a 16-week non-blinded, parallel, controlled trial to determine the feasibility and potential efficacy of an olive oil dietary intervention to alleviate facial pain caused by trigeminal neuralgia type 1 (TGN).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
52

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 27, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 2, 2021

Completed
1 month until next milestone

Study Start

First participant enrolled

October 5, 2021

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2022

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2023

Completed
Last Updated

June 10, 2024

Status Verified

June 1, 2024

Enrollment Period

1.1 years

First QC Date

August 27, 2021

Last Update Submit

June 7, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Compliance to olive oil intervention

    Daily olive oil intake in tablespoons per day.

    12 weeks

Study Arms (2)

Olive Oil

EXPERIMENTAL

Incorporating 60 mL of olive oil into usual diet and Dietary Guidelines recommendations

Dietary Supplement: Olive oil and Dietary Guideline recommendations

Control

ACTIVE COMPARATOR

Dietary Guidelines recommendations

Other: Dietary Guideline recommendations

Interventions

60 mL of olive oil and healthy diet recommendations

Olive Oil

healthy diet recommendations

Control

Eligibility Criteria

Age18 Years - 99 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosed with Trigeminal Neuralgia
  • Able to provide written informed consent in English
  • Self-identifying females 18-99 years of age
  • Willing to consume 60 mL (4 tablespoons) of olive oil and accommodating dietary changes, and thereby achieve weight maintenance.
  • Willing to provide information about dietary intake at baseline, at the study midpoint, and at the end of the study to assess dietary changes.
  • Willing to complete online questionnaires associated with the study.
  • Willing and able to provide a valid social security for study payment purposes.
  • Have access to the internet to complete online questionnaires
  • Willing to maintain confidentiality of the Penn Facial Pain Scale

You may not qualify if:

  • Do not meet the above criteria.
  • Currently participating in another interventional clinical trial.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Food Science and Human Nutrition Department, University of Florida

Gainesville, Florida, 32611, United States

Location

Related Publications (1)

  • Moreno ML, Percival SS, Kelly DL, Dahl WJ. Daily olive oil intake is feasible to reduce trigeminal neuralgia facial pain: A pilot study. Nutr Res. 2024 Mar;123:101-110. doi: 10.1016/j.nutres.2024.01.005. Epub 2024 Jan 10.

MeSH Terms

Conditions

Trigeminal Neuralgia

Interventions

Olive Oil

Condition Hierarchy (Ancestors)

Trigeminal Nerve DiseasesFacial NeuralgiaFacial Nerve DiseasesMouth DiseasesStomatognathic DiseasesCranial Nerve DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

Dietary Fats, UnsaturatedDietary FatsFatsLipidsFats, UnsaturatedPlant OilsOilsFoodDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Officials

  • Wendy J Dahl, PhD

    University of Florida

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 27, 2021

First Posted

September 2, 2021

Study Start

October 5, 2021

Primary Completion

October 31, 2022

Study Completion

March 31, 2023

Last Updated

June 10, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share

Locations